SCHEMBL1725870

SCHEMBL1725870

O=Cc1c(Cl)cccc1Br.[Ar]

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
TDP1 Q9NUW8 1/20 0.67
HSP90AA1 P07900 1/20 0.38
ERN1 O75460 2/20 0.35
CYP2A6 P11509 2/20 0.35
CYP1A2 P05177 1/20 0.33
SLC22A1 O15245 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CHRM1 P11229 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
MAOA P21397 1/20 0.33
DRD1 P21728 1/20 0.33
TBXA2R P21731 1/20 0.33
SLC6A2 P23975 1/20 0.33
ADRA1D P25100 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL611923 0.98 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATDP1HSP90AA1
SCHEMBL31257925 0.98 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATDP1HSP90AA1
SCHEMBL96214 0.81 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATDP1HSP90AA1
SCHEMBL610877 0.81 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATDP1ERN1
SCHEMBL28806185 0.79 ALDH1A1 (0.94) ALDH1A1MEN1KMT2ATDP1HSP90AA1
Hydrogen Sulfide SCHEMBL28185526 0.79 ALDH1A1 (0.94) ALDH1A1MEN1KMT2ATDP1HSP90AA1
SCHEMBL23043311 0.76 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ATDP1HSP90AA1
SCHEMBL31256460 0.76 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ATDP1HSP90AA1
Methylene Chloride SCHEMBL27781504 0.75 ALDH1A1 (0.85) ALDH1A1MEN1KMT2ATDP1HSP90AA1
SCHEMBL31083097 0.74 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ATDP1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403846-B1 INHIBITORS OF BRUTON'S TYROSINE KINASE HOFFMANN LA ROCHE (CH) 2016-11-02 EP disclosed
US-8299077-B2 Inhibitors of Bruton's tyrosine kinase ROCHE PALO ALTO LLC (US) 2012-10-30 US disclosed
EP-2403846-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE F. Hoffmann-La Roche AG (CH) 2012-01-11 EP disclosed
WO-2010100070-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE F. HOFFMANN-LA ROCHE AG (CH) 2010-09-10 WO disclosed
US-20100222325-A1 Inhibitors of Bruton's Tyrosine Kinase BERTHEL STEVEN 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222325-A1 Inhibitors of Bruton's Tyrosine Kinase BTK, SYK, LYN ALDH1A1 4625/4885MEN1 4537/4885KMT2A 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.